Skip to main content
. 2018 Mar 21;16:45. doi: 10.1186/s12916-018-1023-9

Fig. 2.

Fig. 2

Individual and summary odds ratios from pivotal and postapproval trials fulfilling at least two matching criteria and reporting non-continuous endpoints